First Time Loading...

Sierra Oncology Inc
NASDAQ:SRRA

Watchlist Manager
Sierra Oncology Inc Logo
Sierra Oncology Inc
NASDAQ:SRRA
Watchlist
Price: 54.99 USD Market Closed
Updated: Apr 30, 2024

Sierra Oncology Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sierra Oncology Inc
Cash from Financing Activities Peer Comparison

Comparables:
ZYME
RPTX
FUSN
AUPH
EDT

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Sierra Oncology Inc
NASDAQ:SRRA
Cash from Financing Activities
$254.3m
CAGR 3-Years
259%
CAGR 5-Years
56%
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
Cash from Financing Activities
$81.8m
CAGR 3-Years
-36%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Cash from Financing Activities
$842k
CAGR 3-Years
-85%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Cash from Financing Activities
$142m
CAGR 3-Years
-19%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cash from Financing Activities
-$5.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Cash from Financing Activities
CA$5.4m
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
-1%

See Also

What is Sierra Oncology Inc's Cash from Financing Activities?
Cash from Financing Activities
254.3m USD

Based on the financial report for Mar 31, 2022, Sierra Oncology Inc's Cash from Financing Activities amounts to 254.3m USD.

What is Sierra Oncology Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
56%

Over the last year, the Cash from Financing Activities growth was 763%. The average annual Cash from Financing Activities growth rates for Sierra Oncology Inc have been 259% over the past three years , 56% over the past five years .